Clinical trial Recruiting at 1 site Observational Ages 20 and up

Investigating red blood cell function in patients with end-stage renal disease

Official title: The Effect of Osmotic Stress in Erythrocyte Rheology in ESRD Patients

Run by Chang Gung Memorial Hospital · NCT06868888 · Data updated 2026-11-12

This study is trying to see how end-stage kidney disease affects red blood cells and their ability to carry oxygen in patients who are on dialysis.

Quick facts

Study typeObservational
Ages20 Years and up
SexAll
Enrollment40 (estimated)
SponsorChang Gung Memorial Hospital
Academic / other
Locations1 site (Taoyuan)
StatusRecruiting
StartedAugust 24, 2022
Main results expectedMarch 20, 2025
Study endsMarch 26, 2025
Registry record updatedMarch 11, 2025
Trial IDNCT06868888 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 20 years old who have been receiving hemodialysis for at least six weeks and have a Kt/V score greater than 1.2.

Probably not a fit

Patients with recent hyperkalemia, orthopedic or muscular diseases, or other significant medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on how end-stage renal disease (ESRD) affects the deformability of erythrocytes, which is crucial for effective oxygen transport. It examines the relationship between erythrocyte biomechanical properties and aerobic capacity in patients undergoing hemodialysis. The study involves blood collection and cardiopulmonary exercise testing to assess the impact of osmotic imbalances, oxidative stress, and uremic toxins on red blood cell function and microcirculation. By understanding these mechanisms, the research aims to identify potential therapeutic targets to improve vascular health in ESRD patients.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies for enhancing oxygen delivery and overall health in ESRD patients.

How similar studies have gone: While the specific focus on erythrocyte deformability in ESRD is novel, related studies have shown the importance of red blood cell function in various conditions, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Receiving hemodialysis and medication at least for 6 weeks
* Kt/V score \> 1.2

Exclusion Criteria:

* Under 20 years-old
* Hyperkalemia occurs within 3 month
* Having orthopedic or muscular diseases
* Other concerned medical, psychological or physiological diseases
* Pregnancy
* Other exercise contraindications

Where it's running

  • Chang Gung University
    Taoyuan, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.